CR-001

· Crescent Biopharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CR-001, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]